Oxidative triggered release of doxorubicin from poly(sulfide) nanoparticles

A. Rehor, N. Tirelli, J. A. Hubbell

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Abstract

The incorporation and oxidative sensitive release of doxorubicin (DOX), a hydrophobic model drug widely used as a chemotherapeutic agent in cancer therapy, were demonstrated. Particles with mean diameters of 100nm were obtained by polymerizing poly(propylene sulfide) (PPS) in emulsion employing Pluronic F-127 as the only surfactant. Exposure of particles to H2O 2 led to a faster release, with 46% of loaded DOX released after 300h and simultaneous swelling and degradation of the particles. The absence of H2O2 release was assumed to occur by slow protonation of DOX at the Pluronic-PPS-hydrophilic-hydrophobic interface.

Original languageEnglish
Title of host publicationTransactions - 7th World Biomaterials Congress
StatePublished - Dec 1 2004
Externally publishedYes
EventTransactions - 7th World Biomaterials Congress - Sydney, Australia
Duration: May 17 2004May 21 2004

Other

OtherTransactions - 7th World Biomaterials Congress
CountryAustralia
CitySydney
Period5/17/045/21/04

Fingerprint

Nanoparticles
Protonation
Propylene
Emulsions
Swelling
Polypropylenes
Surface active agents
Degradation
Sulfides

ASJC Scopus subject areas

  • Engineering(all)

Cite this

Rehor, A., Tirelli, N., & Hubbell, J. A. (2004). Oxidative triggered release of doxorubicin from poly(sulfide) nanoparticles. In Transactions - 7th World Biomaterials Congress

Oxidative triggered release of doxorubicin from poly(sulfide) nanoparticles. / Rehor, A.; Tirelli, N.; Hubbell, J. A.

Transactions - 7th World Biomaterials Congress. 2004.

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Rehor, A, Tirelli, N & Hubbell, JA 2004, Oxidative triggered release of doxorubicin from poly(sulfide) nanoparticles. in Transactions - 7th World Biomaterials Congress. Transactions - 7th World Biomaterials Congress, Sydney, Australia, 5/17/04.
Rehor A, Tirelli N, Hubbell JA. Oxidative triggered release of doxorubicin from poly(sulfide) nanoparticles. In Transactions - 7th World Biomaterials Congress. 2004
Rehor, A. ; Tirelli, N. ; Hubbell, J. A. / Oxidative triggered release of doxorubicin from poly(sulfide) nanoparticles. Transactions - 7th World Biomaterials Congress. 2004.
@inproceedings{5059a0f27b724bee81893a1b45fced3b,
title = "Oxidative triggered release of doxorubicin from poly(sulfide) nanoparticles",
abstract = "The incorporation and oxidative sensitive release of doxorubicin (DOX), a hydrophobic model drug widely used as a chemotherapeutic agent in cancer therapy, were demonstrated. Particles with mean diameters of 100nm were obtained by polymerizing poly(propylene sulfide) (PPS) in emulsion employing Pluronic F-127 as the only surfactant. Exposure of particles to H2O 2 led to a faster release, with 46{\%} of loaded DOX released after 300h and simultaneous swelling and degradation of the particles. The absence of H2O2 release was assumed to occur by slow protonation of DOX at the Pluronic-PPS-hydrophilic-hydrophobic interface.",
author = "A. Rehor and N. Tirelli and Hubbell, {J. A.}",
year = "2004",
month = "12",
day = "1",
language = "English",
isbn = "1877040193",
booktitle = "Transactions - 7th World Biomaterials Congress",

}

TY - GEN

T1 - Oxidative triggered release of doxorubicin from poly(sulfide) nanoparticles

AU - Rehor, A.

AU - Tirelli, N.

AU - Hubbell, J. A.

PY - 2004/12/1

Y1 - 2004/12/1

N2 - The incorporation and oxidative sensitive release of doxorubicin (DOX), a hydrophobic model drug widely used as a chemotherapeutic agent in cancer therapy, were demonstrated. Particles with mean diameters of 100nm were obtained by polymerizing poly(propylene sulfide) (PPS) in emulsion employing Pluronic F-127 as the only surfactant. Exposure of particles to H2O 2 led to a faster release, with 46% of loaded DOX released after 300h and simultaneous swelling and degradation of the particles. The absence of H2O2 release was assumed to occur by slow protonation of DOX at the Pluronic-PPS-hydrophilic-hydrophobic interface.

AB - The incorporation and oxidative sensitive release of doxorubicin (DOX), a hydrophobic model drug widely used as a chemotherapeutic agent in cancer therapy, were demonstrated. Particles with mean diameters of 100nm were obtained by polymerizing poly(propylene sulfide) (PPS) in emulsion employing Pluronic F-127 as the only surfactant. Exposure of particles to H2O 2 led to a faster release, with 46% of loaded DOX released after 300h and simultaneous swelling and degradation of the particles. The absence of H2O2 release was assumed to occur by slow protonation of DOX at the Pluronic-PPS-hydrophilic-hydrophobic interface.

UR - http://www.scopus.com/inward/record.url?scp=13844296951&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=13844296951&partnerID=8YFLogxK

M3 - Conference contribution

SN - 1877040193

SN - 9781877040191

BT - Transactions - 7th World Biomaterials Congress

ER -